Abstract View

Author(s): Praful Nilkanth Giradkar1

Email(s): 12175principal@msbte.com

Address:

    Shri M. S. Kowase College of Pharmacy, Gadchiroli (M.S.) 442 605

Published In:   Volume - 2,      Issue - 3,     Year - 2023

DOI: Not Available

 View HTML        View PDF

Please allow Pop-Up for this website to view PDF file.

ABSTRACT:
Stroke is one of the most important causes of mortality and morbidity in the world. Prevention and effective treatment of stroke is of the utmost importance. Cerebral ischemia causes disturbances in a variety of cellular and molecular mechanisms, including oxidative phosphorylation, membrane function, neurotransmitter release, and free radical generation. It has been years since tissue-type plasminogen activator (t-PA) became the first medication approved by the FDA for the management of stroke, with limited success. Thrombolytic therapy is the most effective therapeutic strategy for the prevention of brain injury and reduction of mortality in patients with cerebral infarction. However, a combination of established thrombolytic therapy and effective neuronal protection therapy may have more beneficial effects for patients with cerebral infarction. Because clinical trials of pharmacological neuroprotective strategies in stroke have been disappointing, attention has turned towards approaches which include herbal drugs that can be used in limiting the neurological damage associated with stroke. Herbal drugs may be used as prophylactic treatment in patients with high risk of stroke. Herbals drugs have been described in ancient systems of medicine for the treatment of various ailments associated with stroke and have more recently been reported to be beneficial in treating stroke. However, the strength of evidence to support the use of these herbal drugs is unclear. This review focuses on putative mechanisms underlying the beneficial effects of herbal drugs in patients with stroke and on the possibility of herbal drugs to increase the therapeutic time window in patients with cerebral ischemia.

Cite this article:
Mr. Praful Nilkath Giradkar, Herbal Drugs Used in The Treatment of Stroke. IJRPAS, March-April 2023; 2(2): 15-34


References not available.

Related Images:



Recent Images



Methyl Red in Materials Engineering: A Systematic Review of Physicochemical, Energetic and Technological Applications Using the PRISMA Methodology
Nature to Laboratory Translation of Indole Scaffolds: Integrating Natural Product Diversity, Sustainable Synthesis, and Evidence Guided Medicinal Chemistry
Antidiuretic Hormone Deficiency and Central Diabetes Insipidus (Arginine Vasopressin Deficiency): Pathophysiology, Etiology, and Contemporary Management Strategies
Mechanistic Evaluation of Acalypha hispida in Psoriasis Using Network Pharmacology and In-vivo Experimental Models
Formulation and Evaluation of Solubility enhanced Aripiprazole Oro Dispersible Film for the improved patient compliance
LipoEdge™ Liposomal Zinc by WBCIL: From Critical Quality Attributes to Bioavailability Validation and Formulation Applications
Network Pharmacology: A Systems Biology Approach to Drug Discovery and Disease Mechanisms
Artificial Intelligence in Pharmaceutical Formulation Development: From Trial-and-Error to Data-Driven Design
Evaluation of In-Vitro Anti-Diabetic Activity And   Antioxidant Activity In Ethanolic and Hydroalcoholic Extract of leaves of Gymnema Sylvestre
Molecular Docking Approaches in Antibacterial Drug Discovery: Computational Insights into Natural Compounds

Tags